Abstract

AFTER AN EMOTIONAL DEbate, the House of Representatives last week passed a bill that would lift: restrictions on federal funding for development and study of human embryonic stem cell lines derived from excess embryos in fertility clinics. The Stem Cell Research Enhancement Act (H.R. 810) would repeal limitations that provide federal support only for embryonic stem cell lines derived before Aug. 9,2001. The White House pledged to veto the legislation if it clears both the House and Senate. Passed by avote of 238 to 194, the measure has strong bipartisan support in the House but currendy lacks the two-thirds majority needed to override a presidential veto. Bill proponents Sens. Arlen Specter (R-Pa.) andlbm Harkin (D-Iowa), who are hoping to benefit from the momentum generated in the House, have called on the Senate leadership to bring the legislation up for a vote. By passing the bill, the House is moving to reassert America's ethical and scientific ...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.